At present, ReaMetrix is developing an expanding portfolio of reagents and assays for customers in India, the United States and Japan. In particular, we are accessing attractive local reagent opportunities in India as a stepping stone to access the global market. The cost economics of our Indian operation allow us to capture opportunities that have been orphaned by Western research. While our marketing strategy is to approach opportunities with a global view, we focus on local economic paradigms to dictate the nature and implementation of the appropriate tools and technologies. These opportunities are a key component of ReaMetrix’s strategy.


By using Indian scientific resources, we are able to provide an array of products at extremely competitive prices and deliver them to markets in India, the US, Europe and Japan more rapidly than our competitors. In addition, ReaMetrix’s focus on product quality and reproducibility is made cost-effective by our Indian strategy. We believe that the Indian market is an ideal one for the development and introduction of diagnostic products for the developing world. We intend to use the “Indian opportunity” as an incubation center for creating global solutions.